Works matching IS 17052394 AND DT 2014 AND VI 13 AND IP 2
Results: 12
SECOND-GENERATION ALK INHIBITORS.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 28
- By:
- Publication type:
- Article
UPCOMING EVENTS.
- Published in:
- 2014
- Publication type:
- Calendar
SUBGROUP ANALYSES OF CAIRO-3.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 34
- By:
- Publication type:
- Article
COMBINATION CETUXIMAB PLUS FOLFIRI IN PATIENTS WITH MCRC.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 33
- By:
- Publication type:
- Article
NOVEL TREATMENTS TO OVERCOME TKI RESISTANCE.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 31
- By:
- Publication type:
- Article
Drug & therapeutics update.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 38
- Publication type:
- Article
Multiple myeloma.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 26
- By:
- Publication type:
- Article
Lung cancer screening in Canada.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 19
- By:
- Publication type:
- Article
Literature-based followup recommendations.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 12
- By:
- Publication type:
- Article
Oral anti-cancer agents: A paradigm change in cancer treatment.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
It takes a team.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 1
- By:
- Publication type:
- Article
Chronic myeloid leukemia.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 25
- By:
- Publication type:
- Article